Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joseph Codispoti"'
Autor:
Charles McNally, Joseph Codispoti, Michael Shook, Robert J. Weiss, Stephen R. Zellner, E. Eugene Miller, Arthur Stokes, Phillip D. Toth
Publikováno v:
American Journal of Therapeutics. 1:58-64
Previous clinical studies with indapamide, an indoline antihypertensive drug with diuretic and vasodilating activities, have shown a dose relationship associated with potassium loss. Two placebo-controlled, randomized, double-blind, parallel clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380e847cf16c6c472a217cd0549ccc83
https://doi.org/10.1097/00045391-199406000-00010
https://doi.org/10.1097/00045391-199406000-00010
Autor:
Michael A. Weber, Charles McNally, Arthur Stokes, David H.G. Smith, Matthew R. Weir, Stanley S. Franklin, Joseph Codispoti
Publikováno v:
American journal of therapeutics. 3(7)
A multicenter study of the treatment of mild and moderate hypertension compared three once-daily regimens for efficacy and safety: Group I, verapamil sustained release (SR) 240 mg; Group II, verapamil SR 480 mg; and Group III, combination therapy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ceb58ae5dba5aa7f75271d217e0a84
https://pubmed.ncbi.nlm.nih.gov/11862282
https://pubmed.ncbi.nlm.nih.gov/11862282
Autor:
Arthur Stokes, Nader S. Jallad, Adesh K. Jain, Joseph Codispoti, Donald J. Weidler, Charles McNally, Harold W. Schnaper, Phillip D. Toth, Charles L. Curry, Keith C. Ferdinand
Publikováno v:
Journal of clinical pharmacology. 35(1)
A low dose (1.25 mg) of indapamide (Lozol®, Rhone-Poulenc Rorer Pharmaceuticals, Collegeville, PA) was evaluated in 222 elderly patients (≥50 years) with mild to moderate essential hypertension in a multicenter, randomized, double-blind, parallel-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc59db3e12753e4d1a03daf51ef875b
https://pubmed.ncbi.nlm.nih.gov/7751412
https://pubmed.ncbi.nlm.nih.gov/7751412